282 related articles for article (PubMed ID: 23595796)
41. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
[TBL] [Abstract][Full Text] [Related]
42. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of the inflammation reaction and selected indicators of immunity in patients with an infected diabetic ulcer].
Jirkovská A; Fejfarová V; Hosová J; Stríz I; Kalanin J; Skibová J
Cas Lek Cesk; 2002 Aug; 141(15):483-6. PubMed ID: 12226915
[TBL] [Abstract][Full Text] [Related]
44. [Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].
Yang Y; Zhang WG; He AL; Yang HY; Wang JL; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):538-42. PubMed ID: 18549624
[TBL] [Abstract][Full Text] [Related]
45. An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss.
Lee SK; Kim JY; Hur SE; Kim CJ; Na BJ; Lee M; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2011 Nov; 26(11):2964-71. PubMed ID: 21926059
[TBL] [Abstract][Full Text] [Related]
46. [Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis].
Zhang SJ; Xiao HP
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):884-7. PubMed ID: 22333498
[TBL] [Abstract][Full Text] [Related]
47. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
48. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
49. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
50. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
[TBL] [Abstract][Full Text] [Related]
51. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations.
Lewkowicz N; Lewkowicz P; Banasik M; Kurnatowska A; Tchórzewski H
Immunol Lett; 2005 Jun; 99(1):57-62. PubMed ID: 15894112
[TBL] [Abstract][Full Text] [Related]
52. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
[TBL] [Abstract][Full Text] [Related]
53. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens.
Ou LS; Goleva E; Hall C; Leung DY
J Allergy Clin Immunol; 2004 Apr; 113(4):756-63. PubMed ID: 15100684
[TBL] [Abstract][Full Text] [Related]
54. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors.
Haghshenas MR; Khademi B; Faghih Z; Ghaderi A; Erfani N
Immunol Lett; 2015 Apr; 164(2):109-16. PubMed ID: 25739075
[TBL] [Abstract][Full Text] [Related]
55. Early levels in blood of immunoglobulin M and natural killer cells predict outcome in nonseptic critically ill patients.
Andaluz-Ojeda D; Iglesias V; Bobillo F; Nocito M; Loma AM; Nieto C; Ramos E; Gandía F; Rico L; Bermejo-Martin JF
J Crit Care; 2013 Dec; 28(6):1110.e7-1110.e10. PubMed ID: 23953491
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of immune function in the acute phase of Henoch-Schönlein purpura.
Ding Y; Zhou Y; Li HR; Xiong YH; Yin W; Zhao L
Clin Rheumatol; 2021 Sep; 40(9):3711-3716. PubMed ID: 33782751
[TBL] [Abstract][Full Text] [Related]
57. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma.
Yang J; Patil RV; Yu H; Gordon M; Wax MB
Am J Ophthalmol; 2001 Apr; 131(4):421-6. PubMed ID: 11292402
[TBL] [Abstract][Full Text] [Related]
58. [Immunological parameters on prophase of severe hepatitis B].
Guo CH; Deng GJ; Sun TT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):370-2. PubMed ID: 24645326
[TBL] [Abstract][Full Text] [Related]
59. Cytokine profile and lymphocyte subsets in type 2 diabetes.
Francisco CO; Catai AM; Moura-Tonello SC; Arruda LC; Lopes SL; Benze BG; Del Vale AM; Malmegrim KC; Leal AM
Braz J Med Biol Res; 2016; 49(4):e5062. PubMed ID: 27007651
[TBL] [Abstract][Full Text] [Related]
60. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
